nach oben

Pediatric Cardiology

Erschienen in:

02.11.2017 | Review Article

The Roles of Genetic Factors in Kawasaki Disease: A Systematic Review and Meta-analysis of Genetic Association Studies

verfasst von: Xiaochuan Xie, Xiaohan Shi, Meilin Liu

Erschienen in: Pediatric Cardiology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

This systematic review and meta-analysis aimed to better elucidate the roles of genetic factors in Kawasaki disease (KD), and determine the potential genetic biomarkers of KD. The systematic literature search of PubMed, Medline, Embase, Web of Science and CNKI identified 164 eligible studies. The qualitative synthesis revealed that 62 genes may be correlated with the susceptibility to KD, and 47 genes may be associated with the incidence of coronary artery lesions (CALs) in KD. A total of 53 polymorphisms in 34 genes were investigated in further quantitative synthesis. Of these, 23 gene polymorphisms were found to be significantly correlated with KD susceptibility, and 10 gene polymorphisms were found to be significantly associated with the incidence of CALs in KD. In conclusion, our findings indicate that gene polymorphisms of ACE, BLK, CASP3, CD40, FCGR2A, FGβ, HLA-E, IL1A, IL6, ITPKC, LTA, MPO, PD1, SMAD3, CCL17 and TNF may affect KD susceptibility. Besides, genetic variations in BTNL2, CASP3, FCGR2A, FGF23, FGβ, GRIN3A, HLA-E, IL10, ITPKC and TGFBR2 may serve as biomarkers of CALs in KD.

Newburger JW, Takahashi M, Burns JC (2016) Kawasaki disease. J Am Coll Cardiol 67:1738–1749CrossRefPubMed

Dimitriades VR, Brown AG, Gedalia A (2014) Kawasaki disease: pathophysiology, clinical manifestations, and management. Curr Rheumatol Rep 16:423CrossRefPubMed

Fujita Y, Nakamura Y, Sakata K et al (1989) Kawasaki disease in families. Pediatrics 84:666–669PubMed

Nakamura Y, Yashiro M, Uehara R et al (2012) Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey. J Epidemiol 22:216–221CrossRefPubMedPubMedCentral

Holman RC, Christensen KY, Belay ED et al (2010) Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii. Hawaii Med J 69:194–197PubMedPubMedCentral

Salo E, Griffiths EP, Farstad T et al (2012) Incidence of Kawasaki disease in northern European countries. Pediatr Int 54:770–772CrossRefPubMedPubMedCentral

Shulman ST, Rowley AH (2015) Kawasaki disease: insights into pathogenesis and approaches to treatment. Nat Rev Rheumatol 11:475–482CrossRefPubMed

Kim KY, Kim DS (2016) Recent advances in Kawasaki disease. Yonsei Med J 57:15–21CrossRefPubMed

Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264–269CrossRefPubMed

10.

Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605CrossRefPubMed

11.

JCS Joint Working Group (2014) Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version. Circ J 78:2521–2562CrossRef

12.

Shulman ST (2017) Intravenous immunoglobulin for the treatment of Kawasaki disease. Pediatr Ann 46:e25–28CrossRefPubMed

13.

Kim GB, Han JW, Park YW et al (2014) Epidemiologic features of Kawasaki disease in South Korea: data from nationwide survey, 2009-2011. Pediatr Infect Dis J 33:24–27CrossRefPubMed

14.

Lin MC, Lai MS, Jan SL, Fu YC (2015) Epidemiologic features of Kawasaki disease in acute stages in Taiwan, 1997-2010: effect of different case definitions in claims data analysis. J Chin Med Assoc 78:121–126CrossRefPubMed

15.

Greco A, De Virgilio A, Rizzo MI et al (2015) Kawasaki disease: an evolving paradigm. Autoimmun Rev 14:703–709CrossRefPubMed

16.

Takahashi K, Oharaseki T, Yokouchi Y (2014) Update on etio and immunopathogenesis of Kawasaki disease. Curr Opin Rheumatol 26:31–36CrossRefPubMed

17.

Lee HH, Park IH, Shin JS, Kim DS (2009) Immunoglobulin V(H) chain gene analysis of peripheral blood IgM-producing B cells in patients with Kawasaki disease. Yonsei Med J 50:493–504CrossRefPubMedPubMedCentral

18.

Giordani L, Quaranta MG, Marchesi A et al (2011) Increased frequency of immunoglobulin (Ig)A-secreting cells following Toll-like receptor (TLR)-9 engagement in patients with Kawasaki disease. Clin Exp Immunol 163:346–353CrossRefPubMedPubMedCentral

19.

Onouchi Y, Ozaki K, Burns JC et al (2012) A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet 44:517–521CrossRefPubMed

20.

Onouchi Y, Gunji T, Burns JC et al (2008) ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 40:35–42CrossRefPubMed

21.

Onouchi Y, Ozaki K, Buns JC et al (2010) Common variants in CASP3 confer susceptibility to Kawasaki disease. Hum Mol Genet 19:2898–2906CrossRefPubMedPubMedCentral

22.

Lin YJ, Wan L, Wu JY et al (2009) HLA-E gene polymorphism associated with susceptibility to Kawasaki disease and formation of coronary artery aneurysms. Arthritis Rheum 60:604–610CrossRefPubMed

23.

Guo MM, Tseng WN, Ko CH et al (2015) Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease. Allergy 70:310–318CrossRefPubMed

24.

Lee SB, Kim YH, Hyun MC et al (2015) T-Helper cytokine profiles in patients with Kawasaki disease. Korean Circ J 45:516–521CrossRefPubMedPubMedCentral

25.

Ko TM, Kuo HC, Chang JS et al (2015) CXCL10/IP-10 is a biomarker and mediator for Kawasaki disease. Circ Res 116:876–883CrossRefPubMed

26.

Reindel R, Baker SC, Kim KY et al (2013) Integrins α4 and αM, collagen1A1, and matrix metalloproteinase 7 are upregulated in acute Kawasaki disease vasculopathy. Pediatr Res 73:332–336CrossRefPubMed

27.

Braosi AP, de Souza CM, Luczyszyn SM et al (2012) Analysis of IL1 gene polymorphisms and transcript levels in periodontal and chronic kidney disease. Cytokine 60:76–82CrossRefPubMed

28.

Unal S, Gumruk F, Aytac S, Yalnzoglu D, Gurgey A (2008) Interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha) levels and IL-6, TNF-polymorphisms in children with thrombosis. J Pediatr Hematol Oncol 30:26–31CrossRefPubMed

29.

Claudino M, Trombone AP, Cardoso CR et al (2008) The broad effects of the functional IL-10 promoter-592 polymorphism: modulation of IL-10, TIMP-3, and OPG expression and their association with periodontal disease outcome. J Leukoc Biol 84:1565–1573CrossRefPubMed

30.

Guimarães AL, Correia-Silva Jde F, Sá AR et al (2007) Investigation of functional gene polymorphisms IL-1beta, IL-6, IL-10 and TNF-alpha in individuals with recurrent aphthous stomatitis. Arch Oral Biol 52:268–272CrossRefPubMed

31.

Liu F, Ding Y, Yin W (2015) Association of single nucleotide polymorphisms in TARC/CCL17 gene with Kawasaki disease and its clinical characteristics. Zhongguo Dang Dai Er Ke Za Zhi 17:668–671PubMed

32.

Orenstein JM, Shulman ST, Fox LM et al (2012) Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS ONE 7:e38998CrossRefPubMedPubMedCentral

33.

Takahashi K, Oharaseki T, Yokouchi Y, Naoe S, Saji T (2013) Kawasaki disease: basic and pathological findings. Clin Exp Nephrol 17:690–693CrossRefPubMed

34.

Ceron CS, Rizzi E, Guimarães DA et al (2013) Nebivolol attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMPs, and decreasesvascular remodeling in renovascular hypertension. Free Radic Biol Med 65:47–56CrossRefPubMed

35.

Ota R, Kurihara C, Tsou TL et al (2009) Roles of matrix metalloproteinases in flow-induced outward vascular remodeling. J Cereb Blood Flow Metab 29:1547–1558CrossRefPubMedPubMedCentral

36.

Tsujino K, Reed NI, Atakilit A, Ren X, Sheppard D (2017) Transforming growth factor-β plays divergent roles in modulating vascular remodeling, inflammation, and pulmonary fibrosis in a murine model of scleroderma. Am J Physiol Lung Cell Mol Physiol 312:L22–31CrossRefPubMed

37.

Guimarães DA, Rizzi E, Ceron CS et al (2015) Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension. Redox Biol 6:386–395CrossRefPubMedPubMedCentral

38.

Gao F, Chambon P, Tellides G et al (2014) Disruption of TGF-β signaling in smooth muscle cell prevents flow-induced vascular remodeling. Biochem Biophys Res Commun 454:245–250CrossRefPubMed

39.

Hassoun PM, Mouthon L, Barberà JA et al (2009) Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol 54(1 Suppl):S10–19CrossRefPubMed

40.

Assal Y, Mie M, Kobatake E (2013) The promotion of angiogenesis by growth factors integrated with ECM proteins through coiled-coil structures. Biomaterials 34:3315–3323CrossRefPubMed

41.

Levi M, van der Poll T (2005) Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med 15:254–259CrossRefPubMed

42.

Straface E, Marchesi A, Gambardella L et al (2012) Does oxidative stress play a critical role in cardiovascular complications of Kawasaki disease? Antioxid Redox Signal 17:1441–1446CrossRefPubMed

43.

Pincetic A, Bournazos S, DiLillo DJ et al (2014) Type I and type II Fc receptors regulate innate and adaptive immunity. Nat Immunol 15:707–716CrossRefPubMed

44.

Getahun A, Cambier JC (2015) Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin Fc receptor signaling. Immunol Rev 268:66–73CrossRefPubMedPubMedCentral

45.

Khor CC, Davila S, Breunis WB et al (2011) Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet 43:1241–1246CrossRefPubMed

46.

Kuo HC, Hsu YW, Wu MS et al (2016) Intravenous immunoglobulin, pharmacogenomics, and Kawasaki disease. J Microbiol Immunol Infect 49:1–7CrossRefPubMed

47.

Satou GM, Giamelli J, Gewitz MH (2007) Kawasaki disease: diagnosis, management, and long-term implications. Cardiol Rev 15:163–169CrossRefPubMed

48.

Saguil A, Fargo M, Grogan S (2015) Diagnosis and management of kawasaki disease. Am Fam Physician 91:365–371PubMed

Titel: The Roles of Genetic Factors in Kawasaki Disease: A Systematic Review and Meta-analysis of Genetic Association Studies
verfasst von: Xiaochuan Xie
Xiaohan Shi
Meilin Liu
Publikationsdatum: 02.11.2017
Verlag: Springer US
Erschienen in: Pediatric Cardiology / Ausgabe 2/2018
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI: https://doi.org/10.1007/s00246-017-1760-0

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2018

Myocardial Fistulisation and Coronary Arterial Ectasia in Children with Univentricular Circulation: An Under-Recognised Problem

Oxidation Reduction Potential (ORP) is Predictive of Complications Following Pediatric Cardiac Surgery

RCAN1 Mutation and Functional Characterization in Children with Sporadic Congenital Heart Disease

Reintervention Burden and Vessel Growth After Surgical Reimplantation of a Pulmonary Artery During Childhood